Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04262180 · ClinicalTrials.gov registry record · NA

Physical Activity Promotion for Breast and Endometrial Cancer Survivors

A NA study of Physical Activity and Breast Cancer Survivors, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
323
Enrollment target
2
Study locations

NCT04262180: Completed NA study of Physical Activity and Breast Cancer Survivors, sponsored by University of Wisconsin, Madison.

NCT04262180 is a NA study of Physical Activity and Breast Cancer Survivors that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 323 participants, roughly in line with the 356-participant average among 131 other Physical Activity trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04262180, a NA study of Physical Activity and Breast Cancer Survivors, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
323 participants
Enrollment target
2
Study locations

Study Summary

Many breast and endometrial cancer survivors do not get enough physical activity. Technology-based interventions can be inexpensive and easy to scale up, however they are not effective for all women. The purpose of this study is test an adaptive physical activity intervention approach that reserves the most resources and support for women who do not fare well with a lower-cost, minimal intervention. The results from this trial will inform the development of scalable physical activity interventions for breast and endometrial cancer survivors.

Primary Outcome

Change in the 'Weekly minutes of moderate- to-vigorous physical activity (MVPA)' as measured by actigraph

Interventions

  • OTHER Base intervention-Fitbit with EHR integration
  • OTHER Coaching Calls
  • OTHER Online Gym

Study Locations (2)

Illinois

  • Department of Preventative Medicine, Northwestern University - Chicago

Wisconsin

  • Department of Kinesiology, University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 323 participants
Start Date 2020-11-09
Est. Completion 2025-09-15
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT04262180 record still lists

NCT04262180 is an interventional study that assigns participants to a tested intervention. The registered 323 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 356-participant average among 131 other Physical Activity trials with a reported enrollment target.

The record links to 3 conditions, with Physical Activity appearing as the primary indexed condition, and to 3 interventions - of which Base intervention-Fitbit with EHR integration is the first listed.

NCT04262180 reports a single indexed study location in Illinois, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04262180 about?

NCT04262180 is a clinical study titled "Physical Activity Promotion for Breast and Endometrial Cancer Survivors". Many breast and endometrial cancer survivors do not get enough physical activity. Technology-based interventions can be inexpensive and easy to scale up, however they are not effective for all women. The purpose of this study is test an adaptive physical activity intervention approach that reserves ...

What is the current status of trial NCT04262180?

This trial is currently completed. It is a NA study. The enrollment target is 323 participants. The study started on 2020-11-09. Estimated completion is 2025-09-15.

What conditions does trial NCT04262180 study?

This clinical trial studies the following conditions: Physical Activity, Breast Cancer Survivors, Endometrial Cancer Survivors.

What interventions are being tested in trial NCT04262180?

The interventions under investigation include: Base intervention-Fitbit with EHR integration (OTHER), Coaching Calls (OTHER), Online Gym (OTHER).

Who is sponsoring clinical trial NCT04262180?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04262180 being conducted?

This trial has 2 study locations across Illinois, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04262180's enrollment target sits among peer trials

323 32nd of 131 higher than 100 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04164173 · 324 participants · NA

    Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

  • NCT04708054 · 324 participants · Phase 2

    Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

  • NCT05261399 · 324 participants · Phase 3

    Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

  • NCT05353322 · 324 participants · NA

    Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04262180, the US trial registry maintained by the National Library of Medicine. NCT04262180 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.